GE HEALTHCARE TECH.INC. (L0T) — Capital Reinvestment Ratio

Latest as of March 2026: 0.61x

GE HEALTHCARE TECH.INC. (L0T) has a Capital Reinvestment Ratio of 0.61x as of March 2026, meaning it reinvests 1% of its operating cash flow (€290.00 Million) in capital expenditures (€178.00 Million). See net asset quality index of GE HEALTHCARE TECH.INC. to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.61x
Capex / Operating Cash Flow

Operating Cash Flow

€290.00 Million
EUR

Capital Expenditures

€178.00 Million
EUR

Data as of

Mar 2026
Most recent filing

GE HEALTHCARE TECH.INC. Capital Reinvestment Ratio (2022–2025)

This chart tracks GE HEALTHCARE TECH.INC.'s Capital Reinvestment Ratio across 4 annual periods. Check how aggressively does GE HEALTHCARE TECH.INC. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for GE HEALTHCARE TECH.INC. (2022–2025)

Year-by-year Capital Reinvestment Ratio for GE HEALTHCARE TECH.INC. from 2022 to 2025. For live market cap and broader valuation context, see L0T stock market capitalisation.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.24x €1.99 Billion €482.00 Million ▲ +18.0%
2024 0.21x €1.95 Billion €401.00 Million ▲ +11.6%
2023 0.18x €2.10 Billion €387.00 Million ▲ +25.6%
2022 0.15x €2.11 Billion €310.00 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow